Ultragenyx Pharmaceutical (RARE) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Ultragenyx Pharmaceutical (RARE) over the last 10 years, with Q3 2025 value amounting to $5.9 million.
- Ultragenyx Pharmaceutical's Interest & Investment Income fell 4536.39% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.0 million, marking a year-over-year decrease of 2103.97%. This contributed to the annual value of $36.5 million for FY2024, which is 3678.81% up from last year.
- As of Q3 2025, Ultragenyx Pharmaceutical's Interest & Investment Income stood at $5.9 million, which was down 4536.39% from $5.8 million recorded in Q2 2025.
- Ultragenyx Pharmaceutical's Interest & Investment Income's 5-year high stood at $10.7 million during Q3 2024, with a 5-year trough of $408000.0 in Q3 2021.
- In the last 5 years, Ultragenyx Pharmaceutical's Interest & Investment Income had a median value of $5.9 million in 2023 and averaged $5.0 million.
- Its Interest & Investment Income has fluctuated over the past 5 years, first crashed by 7810.89% in 2021, then surged by 130863.64% in 2022.
- Over the past 5 years, Ultragenyx Pharmaceutical's Interest & Investment Income (Quarter) stood at $440000.0 in 2021, then skyrocketed by 1308.64% to $6.2 million in 2022, then soared by 38.0% to $8.6 million in 2023, then grew by 11.66% to $9.5 million in 2024, then plummeted by 38.61% to $5.9 million in 2025.
- Its last three reported values are $5.9 million in Q3 2025, $5.8 million for Q2 2025, and $6.8 million during Q1 2025.